Download DNB 2019 Dec 2019 Dec GASTROENTEROLOGY PAPER III Question Paper

Download Diplomate in National Board (DNB) 2019 Dec 2019 Dec GASTROENTEROLOGY PAPER III Previous Question Papers

FINAL EXAM
DECEMBER 2019
Time: 3 hours
NATIONAL BOARD OF EXAMINATIONS
GASTROENTEROLOGY
PAPER?lll
Max. Marksz100
Important Instructions:
Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legib/y.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer a// the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/?owcharts Wherever appropriate.
Write short notes on:
1. a)
b)
C)
2. a)
b)
C)
Staging of Hepatocellular Carcinoma (HCC).
Post TACE syndrome.
Recent advances in systemic therapy in HCC.
Minimal hepatic encephalopathy (MHE) - definition.
Tests for diagnosis of MHE.
Management of MHE.
Normal gut flora.
Indications for Fecal Microbiota Transplantation (FMT).
Complications of FMT.
WHO classification of Primary tumours of the Exocrine
Pancreas.
Resectability in Carcinoma Pancreas.
Management of unresectable Carcinoma Pancreas.
Lifestyle changes in management of NAFLD.
Newer drugs in NAFLD treatment.
Genetics of NAFLD.
Clinical features of Whipple?s disease.
Diagnosis of Whipple?s disease.
Management of Whipple?s disease.
Types of Lumen apposing metallic stents in GI practice.
Indications for Lumen apposing metallic stents.
Complications of Lumen apposing metallic stents.
Surveillance in post colectomy Familial Adenomatous Polyposis
syndrome patients.
Chemoprevention of Colorectal Carcinoma.
-1-
GASTRO/D/19/10/III
3+3+4
2+3+5
3+4+3
3+3+4
3+3+4
3+3+4
3+4+3
5+5
P.T.O
I?OSSESSION/USE OF CELL PHONES OR ANYSUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXA MINA TION HALL.

FINAL EXAM NATIONAL BOARD OF EXAMtNATIONS
DECEMBER 2019
GASTROENTEROLOGY
PAPER?lll
9. a) Transientelastography in NAFLD. 3+4+3
b) Noninvasive serum markers for fibrosis of liver.
0) Indications for liver biopsy in NAFLD.
10. a) Biosimilar in Gastroenterology practice. 4+3+3
b) Various formulations of mesalamine.
0) Therapeutic drug monitoring for Anti TNF agents in IBD.
*~k*?k**********
-2-
I?OSSESS/ON/USE OF CELL PHONES OR ANYSUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EX/I MINA TION l'I/I LL.